TSANTRIZOS, Youla S

$160,000.00 CAD

≈ 2 Canadians' average pay for a year
Department
Canadian Institutes of Health Research
Program
Recipient country
Canada
Fiscal year
2014-2015
Agreement period
April 1, 2014 – March 31, 2015
Reference
cihr-irsc:236-2013-2014-Q4-00463

Published purpose

Benchmark proprietary pyridine- and thienopyrimidine-based bisphosphonates against the standard of care drug Zometa® in the treatment of multiple myeloma

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions